NCT06205667

Brief Summary

The aim of the study is to evaluate the applicability, accuracy, benefits and the efficacy of 3-dimensional, printed, patient-specific guides to direct TMJ access for arthrocentesis when performed in contrast with conventional arthrocentesis of TMJ.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
22

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2021

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2023

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2023

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

January 4, 2024

Completed
12 days until next milestone

First Posted

Study publicly available on registry

January 16, 2024

Completed
Last Updated

January 16, 2024

Status Verified

March 1, 2021

Enrollment Period

1.7 years

First QC Date

January 4, 2024

Last Update Submit

January 4, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Attempts number of needle puncture

    intraoperative

  • Operation time started from first needle insertion.

    intaoperative

Secondary Outcomes (2)

  • Maximum mouth opening

    1week, 1, 3 and 6

  • Pain reduction

    1week, 1, 3 and 6

Study Arms (2)

Computer Guided Arthrocentesis

EXPERIMENTAL

a study group injected intra-articularly through TMJ using a computer-guided template.

Procedure: Computer Guided Arthrocentesis

Conventional Arthrocentesis

ACTIVE COMPARATOR

a control group which injected intra-articular through TMJ using conventional method based on anatomical landmark determination

Procedure: Conventional Arthrocentesis

Interventions

patients are going to be injected intra-articular within the superior joint space of the affected TMJ through custom guided template planned in a manner inspired by earphone design to get support from the tragus.

Computer Guided Arthrocentesis

patients are going to be injected intra-articular within the superior joint space of the affected TMJ using conventional method anatomical landmark determination

Conventional Arthrocentesis

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Patients who complain from signs and symptoms of internal derangements and were diagnosed by the RDC/TMD as having disc displacement with/ without reduction with / without limitation associated with arthralgia or as having disc displacement with reduction associated with arthralgia in a presence or absence of joint sounds.
  • Patients who did not responded to conservative treatment for a minimum of 3 months.
  • Obtaining written informed consents signed by the patients.

You may not qualify if:

  • Patients suffering from any muscular disorders as myofascial pain or myofascial pain with limitations
  • If the disc was not visible in the MRI examination.
  • Patients who previously received intra-articular injection of any medication or exposed to any other TMJ invasive procedure.
  • Patients who suffer from any connective tissue diseases as rheumatoid arthritis or neurologic disorders.
  • Patients with history of major jaw trauma, bisphosphonate-derived drug use, pregnancy, alcohol or drug dependence.
  • Patients with gross mechanical restrictions or history of adhesion (fibrous or bony).
  • Patients with psychiatric disease or substance abuse or have an allergy to the substance used in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ainshams university

Cairo, Egypt

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 4, 2024

First Posted

January 16, 2024

Study Start

June 1, 2021

Primary Completion

March 1, 2023

Study Completion

September 30, 2023

Last Updated

January 16, 2024

Record last verified: 2021-03

Locations